Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients' perspectives

Afr J Prim Health Care Fam Med. 2017 Oct 17;9(1):e1-e9. doi: 10.4102/phcfm.v9i1.1411.

Abstract

Background: Little is known about the experiences of Ethiopian patients with type 2 diabetes related to adherence to their anti-diabetic medications. This may limit attempts to develop and implement patient-centred approaches that consider Ethiopian contexts.

Objectives: To conduct an exploratory study with a focus on identifying barriers and facilitators to anti-diabetic medications adherence in Ethiopian patients with type 2 diabetes.

Methods: Qualitative methods were used to conduct semi-structured interviews with 39 purposively selected participants attending clinic in three public hospitals in central Ethiopia. Open coding was used to analyse the data to identify key themes.

Results: A number of factors were identified as barriers and facilitators to participants' adherence to their anti-diabetic medications. The most common factors were perceptions related to their illness including symptoms, consequences and curability; perceptions of medications including safety concerns, convenience and their necessity; religious healing practices and beliefs; perceptions about and experiences with their healthcare providers and the healthcare system including the availability of medications and diabetes education; and finally perceived self-efficacy and social support.

Conclusions: The findings of this study provide guidance to strengthen diabetes education programmes so that they reflect local patient contexts focusing among other things on the illness itself and the anti-diabetic medications.

Publication types

  • Evaluation Study
  • Multicenter Study

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Ethiopia
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Interviews as Topic
  • Male
  • Medication Adherence / statistics & numerical data*
  • Qualitative Research

Substances

  • Hypoglycemic Agents